Jed Ross

3.1k total citations · 1 hit paper
18 papers, 1.4k citations indexed

About

Jed Ross is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Cancer Research. According to data from OpenAlex, Jed Ross has authored 18 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 7 papers in Radiology, Nuclear Medicine and Imaging and 4 papers in Cancer Research. Recurrent topics in Jed Ross's work include MRI in cancer diagnosis (6 papers), Advanced MRI Techniques and Applications (5 papers) and Angiogenesis and VEGF in Cancer (4 papers). Jed Ross is often cited by papers focused on MRI in cancer diagnosis (6 papers), Advanced MRI Techniques and Applications (5 papers) and Angiogenesis and VEGF in Cancer (4 papers). Jed Ross collaborates with scholars based in United States, France and Canada. Jed Ross's co-authors include Nicholas van Bruggen, Richard A.D. Carano, Napoleone Ferrara, Franklin Peale, Xiumin Wu, Calvin Ho, Renhui Yang, Hongkui Jin, Xiao‐Huan Liang and Jenny Yao and has published in prestigious journals such as Nature, Journal of Biological Chemistry and Hepatology.

In The Last Decade

Jed Ross

18 papers receiving 1.4k citations

Hit Papers

Bv8 regulates myeloid-cell-dependent tumour angiogenesis 2007 2026 2013 2019 2007 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jed Ross United States 15 690 454 389 289 237 18 1.4k
Donna Hylton United States 8 1.2k 1.8× 544 1.2× 347 0.9× 356 1.2× 543 2.3× 12 2.3k
David R. Emlet United States 16 1.3k 1.9× 598 1.3× 261 0.7× 231 0.8× 155 0.7× 24 2.1k
Paolo Esposto Pirani Italy 15 347 0.5× 651 1.4× 387 1.0× 136 0.5× 206 0.9× 31 1.3k
Rachelle W. Johnson United States 26 907 1.3× 1.0k 2.3× 225 0.6× 295 1.0× 145 0.6× 55 1.8k
Kiyotaka Yokogami Japan 17 656 1.0× 393 0.9× 238 0.6× 218 0.8× 150 0.6× 70 1.5k
April A. N. Rose Canada 21 958 1.4× 998 2.2× 336 0.9× 307 1.1× 205 0.9× 57 1.9k
Douglas Armellino United States 15 1.3k 1.9× 738 1.6× 247 0.6× 401 1.4× 444 1.9× 18 2.3k
Alberto Pisacane Italy 21 486 0.7× 624 1.4× 192 0.5× 269 0.9× 147 0.6× 49 1.4k
William Benedict United States 6 912 1.3× 267 0.6× 159 0.4× 295 1.0× 347 1.5× 9 1.7k
P Wülfing Germany 22 773 1.1× 576 1.3× 194 0.5× 452 1.6× 84 0.4× 47 1.7k

Countries citing papers authored by Jed Ross

Since Specialization
Citations

This map shows the geographic impact of Jed Ross's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jed Ross with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jed Ross more than expected).

Fields of papers citing papers by Jed Ross

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jed Ross. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jed Ross. The network helps show where Jed Ross may publish in the future.

Co-authorship network of co-authors of Jed Ross

This figure shows the co-authorship network connecting the top 25 collaborators of Jed Ross. A scholar is included among the top collaborators of Jed Ross based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jed Ross. Jed Ross is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Schutt, Leah, Jacqueline M. Tarrant, Michelle McDowell, et al.. (2016). Bruton’s Tyrosine Kinase Small Molecule Inhibitors Induce a Distinct Pancreatic Toxicity in Rats. Journal of Pharmacology and Experimental Therapeutics. 360(1). 226–238. 12 indexed citations
2.
Huntzicker, Erik G., Kathy Hötzel, Lisa Choy, et al.. (2014). Differential effects of targeting Notch receptors in a mouse model of liver cancer. Hepatology. 61(3). 942–952. 84 indexed citations
3.
Moriya, Junji, Xiumin Wu, Jose Zavala‐Solorio, et al.. (2013). Platelet-derived growth factor C promotes revascularization in ischemic limbs of diabetic mice. Journal of Vascular Surgery. 59(5). 1402–1409.e4. 32 indexed citations
4.
Shi, Yunzhou, Jason Oeh, Jeffrey Eastham‐Anderson, et al.. (2013). Mapping In Vivo Tumor Oxygenation within Viable Tumor by 19F-MRI and Multispectral Analysis. Neoplasia. 15(11). 1241–IN1. 17 indexed citations
5.
Pacheco, Glenn, Calvin Ho, Sharon Yee, et al.. (2011). Vessel imaging with viable tumor analysis for quantification of tumor angiogenesis. Magnetic Resonance in Medicine. 65(3). 889–899. 11 indexed citations
6.
Pacheco, Glenn, Calvin Ho, Sharon Yee, et al.. (2010). Vessel imaging with viable tumor analysis for quantification of tumor angiogenesis. Magnetic Resonance in Medicine. 63(6). 1637–1647. 43 indexed citations
7.
Leow, Ching Ching, Bu-Er Wang, Jed Ross, et al.. (2009). Prostate-specific Klf6 Inactivation Impairs Anterior Prostate Branching Morphogenesis through Increased Activation of the Shh Pathway. Journal of Biological Chemistry. 284(31). 21057–21065. 19 indexed citations
8.
Barck, Kai, Brandon Willis, Jed Ross, et al.. (2009). Viable tumor tissue detection in murine metastatic breast cancer by whole‐body MRI and multispectral analysis. Magnetic Resonance in Medicine. 62(6). 1423–1430. 10 indexed citations
9.
Mařı́k, Jan, Annie Ogasawara, Baby Martin-McNulty, et al.. (2009). PET of Glial Metabolism Using 2-18F-Fluoroacetate. Journal of Nuclear Medicine. 50(6). 982–990. 35 indexed citations
10.
Strickland, Laura A, Jed Ross, Simon A. Williams, et al.. (2009). Preclinical evaluation of carcinoembryonic cell adhesion molecule (CEACAM) 6 as potential therapy target for pancreatic adenocarcinoma. The Journal of Pathology. 218(3). 380–390. 51 indexed citations
11.
Korsisaari, Nina, Jed Ross, Xiumin Wu, et al.. (2008). Blocking Vascular Endothelial Growth Factor-A Inhibits the Growth of Pituitary Adenomas and Lowers Serum Prolactin Level in a Mouse Model of Multiple Endocrine Neoplasia Type 1. Clinical Cancer Research. 14(1). 249–258. 49 indexed citations
12.
Berry, Leanne, Kai Barck, Mary Ann T. Go, et al.. (2008). Quantification of viable tumor microvascular characteristics by multispectral analysis. Magnetic Resonance in Medicine. 60(1). 64–72. 40 indexed citations
13.
Jin, Hongkui, Renhui Yang, Jed Ross, et al.. (2008). Cooperation of the Agonistic DR5 Antibody Apomab with Chemotherapy to Inhibit Orthotopic Lung Tumor Growth and Improve Survival. Clinical Cancer Research. 14(23). 7733–7740. 51 indexed citations
14.
Shojaei, Farbod, Xiumin Wu, Cuiling Zhong, et al.. (2007). Bv8 regulates myeloid-cell-dependent tumour angiogenesis. Nature. 450(7171). 825–831. 522 indexed citations breakdown →
15.
Seshasayee, Dhaya, Hua Wang, Wyne P. Lee, et al.. (2004). A Novel in Vivo Role for Osteoprotegerin Ligand in Activation of Monocyte Effector Function and Inflammatory Response. Journal of Biological Chemistry. 279(29). 30202–30209. 56 indexed citations
16.
Jin, Hongkui, Renhui Yang, Sharon Fong, et al.. (2004). Apo2 Ligand/Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Cooperates with Chemotherapy to Inhibit Orthotopic Lung Tumor Growth and Improve Survival. Cancer Research. 64(14). 4900–4905. 97 indexed citations
17.
Carano, Richard A.D., Jed Ross, Simon P. Williams, et al.. (2004). Quantification of tumor tissue populations by multispectral analysis. Magnetic Resonance in Medicine. 51(3). 542–551. 76 indexed citations
18.
Yang, Renhui, Glyn Thomas, Stuart Bunting, et al.. (1996). Effects of Vascular Endothelial Growth Factor on Hemodynamics and Cardiac Performance. Journal of Cardiovascular Pharmacology. 27(6). 838–844. 203 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026